Hematocrit and C-reactive protein predict treatment response times in ADAMTS13-deficient thrombotic microangiopathy

2011 ◽  
Vol 26 (3) ◽  
pp. 138-145
Author(s):  
Noelle I. Samia ◽  
Kenneth D. Friedman ◽  
Jerome L. Gottschall ◽  
Thomas J. Raife
PLoS ONE ◽  
2017 ◽  
Vol 12 (2) ◽  
pp. e0171229 ◽  
Author(s):  
Ashutosh Sharma ◽  
Gordon Kirkpatrick ◽  
Virginia Chen ◽  
Kate Skolnik ◽  
Zsuzsanna Hollander ◽  
...  

2017 ◽  
Vol 42 (1) ◽  
pp. 33-38 ◽  
Author(s):  
C Jiménez-Garrido ◽  
J M Gómez-Palomo ◽  
I Rodriguez-Delourme ◽  
F J Durán-Garrido ◽  
E Nuño-Álvarez ◽  
...  

2009 ◽  
pp. NA-NA ◽  
Author(s):  
Yasuko O. Erickson ◽  
Noelle I. Samia ◽  
Bruce Bedell ◽  
Kenneth D. Friedman ◽  
Bonnie S. Atkinson ◽  
...  

2021 ◽  
Vol 14 (6) ◽  
pp. e243334
Author(s):  
Alexander Hackney ◽  
Sunil James ◽  
Surendra Karanam

C reactive protein (CRP) is an inflammatory protein that is often used in conjunction with the clinical presentation of a patient to help with quantifying infection severity and measuring treatment response. We report the case of a patient who presented with severe pneumonias but had a suboptimal CRP response, later diagnosed as having an underlying immunodeficiency. This case exemplifies the need to consider immunodeficiency as an underlying pathophysiological cause in patients presenting with complicated and severe infections.


PLoS ONE ◽  
2015 ◽  
Vol 10 (12) ◽  
pp. e0143080 ◽  
Author(s):  
Shiva Shrotriya ◽  
Declan Walsh ◽  
Nabila Bennani-Baiti ◽  
Shirley Thomas ◽  
Cliona Lorton

2021 ◽  
Vol 20 ◽  
pp. S78
Author(s):  
D. VanDevanter ◽  
S. Heltshe ◽  
M. Skalland ◽  
N. West ◽  
D. Sanders ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document